Pharmafile Logo
Pharmafocus logo
Advanced Search
keytruda1

MSD receives fourth Breakthrough Therapy Designation for Keytruda

April 19, 2016
Manufacturing and Production, Research and Development Breakthrough Therapy Designation, FDA, Hodgkin lymphoma, MSD, Merck, breakthrough designation, breakthrough therapy, keytruda

MSD (NYSE: MRK) has announced that the US Food and Drug Administration has granted Breakthrough Therapy Designation to Keytruda (pembrolizumab) …

News
sanofi_hq__boetie_hall

Sanofi invests €300 million in new Belgian biologics site

April 19, 2016
Manufacturing and Production Belgium, Sanofi, belgian, flanders, geel, investment, manufacturing, pipeline

Sanofi has announced plans to expand its site in Geel, Belgium, with a €300 million investment to support its pipeline …

News
clinicaltrial

FDA rejects Chiasma’s new drug application for therapy to treat rare growth disorder

April 18, 2016
Research and Development, Sales and Marketing Chiasma Inc, US FDA, drug trial, rare disease

Shares in Chiasma Inc (Nasdaq: CHMA) plunged to more than halve on the Nasdaq Monday as the company reported the …

News
novo_corp_hq2

Novo unveils new research grant to mark World Haemophilia Day

April 18, 2016
Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, grant, haemophilia, hero, world haemophilia day

Novo Nordisk has marked World Haemophilia Day 2016 with the announcement of a new research grant aimed at supporting and …

News
tablet_production_2

British Biosimilars Association launches in UK

April 18, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Napp, bba, bgma, british biosimilars association

A new industry body, the British Biosimilars Association, has been formally launched today with the sole focus of increasing the …

News
stocks1

Weekly Movers: Valeant, Depomed, Intercept Pharma, Insys Therapeutics and more…

April 18, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Depomed, Intercept Pharma, Relypsa, Share price, Stock Movement, Valeant, stock market

Troubles don’t seem to go away for Canada-based Valeant Pharma (NYSE: VRX) with news of a probable sale doing the …

Feature
boots2

Sticking the boot in

April 18, 2016
Sales and Marketing Boots, Cost, Guardian, NHS, prescribing, scandal, unfair

A recent exposé has shone a light on the practices allegedly enforced at the nation’s largest pharmacy. So what exactly …

Feature
clinicaltrial1

Sosei‘s Heptares And Kymab to collaborate on developing new antibody therapeutics

April 18, 2016
Research and Development, Sales and Marketing Heptares Therapeutics, Kymab Ltd, Sosei Group, collaboration, drug development, immuno-oncology

Japan’s Sosei Group Corp (TSE: 4565) has signed a collaboration deal with Kymab Ltd to develop and market novel antibody …

News
gavel

Roche sues Intas Pharma over patent dispute in India

April 18, 2016
Medical Communications, Sales and Marketing India, Roche, anaemia, chronic kidney, intas, intas pharmaceuticals, patent

Roche Pharmaceuticals is suing Indian-based Intas Pharmaceuticals, alleging that the company has infringed upon its patent rights to anaemia drug, …

News
drugs1

NICE recommends PTC Therapeutics’ Translarna to treat Duchenne muscular dystrophy

April 18, 2016
Sales and Marketing DMD, Duchenne Muscular Dystrophy, NICE, PTC Therapeutics, Translarna, regulation

Shares in drug maker PTC Therapeutics (Nasdaq: PTCT) jumped after the National Institute for Health and Care Excellence (NICE) backed …

News
shire_image

Shire announces new $400 million biologics plant and 400 new jobs in Ireland

April 18, 2016
Manufacturing and Production, Sales and Marketing IDA, Ireland, Shire, investment, meath, shire pharmaceuticals

Shire Pharmaceuticals has announced the expansion of its Irish operations with a new $400 million biologics plant set to deliver …

News
astrazeneca_building_white

AstraZeneca hold internal talks for Medivation takeover – reports

April 18, 2016
Manufacturing and Production, Sales and Marketing 7 billion, AstraZeneca, Medivation, Sanofi, jp morgan, merger, takeover

AstraZeneca (LSE: AZN) is said to have held initial internal talks concerning a potential £7 billion offer for US drug …

News
paris

Clinical trial initiated to help Paris attacks victims with PTSD

April 15, 2016
Medical Communications, Research and Development France, clinical trial, mcgill, mcgill university, terror attacks

Victims of the recent Paris terror attacks have been offered the opportunity to take part in a clinical trial, organised …

News
gilead-sciences

Gilead Sciences says Phase III trials for chronic HBV drug meet primary endpoints

April 15, 2016
Gilead Sciences, US FDA, chronic hepatitis B, drug trial

Biotech firm Gilead Sciences (NYSE: GILD) on Friday announced positive results from late-stage trials for its drug to treat chronic …

News
hospital

Repros Therapeutics says positive results from Phase II trial of uterine fibroids drug; shares jump

April 15, 2016
Medical Communications, Research and Development Repros Therapeutics, Shares, US FDA, drug trial, uterine fibroids

Shares in Repros Therapeutics (Nasdaq: RPRX) surged to close over 18% Thursday after the company announced positive mid-stage trial results …

News
pfizerbrussels

Pfizer fined for epilepsy drug price increase by UK antitrust regulator

April 15, 2016
Medical Communications CMA, Flynn Pharma, Pfizer, antitrust, competition and markets authority, epilepsy, fine, flynn

Pfizer has been fined for unfairly increasing the price of epilepsy drug Epanutin (phenytoin sodium) by the UK Competition and …

News
shutterstock_211705468

US annual spending on drugs rose 12.2% in 2015 – IMS

April 15, 2016
Medical Communications, Research and Development, Sales and Marketing IMS Health, drug spending

The total US spending on prescription drugs rose 12.2% to almost $425 billion in 2015 on the back of new …

News
cancer_cells

Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer

April 15, 2016
Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university

Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …

News
clinical_trial_4

Synta Pharmaceuticals announces merger with Madrigal

April 15, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Phase II, Synta, madrigal, merger

Synta Pharmaceuticals (NASDAQ: SNTA) has announced a definitive merger agreement with Madrigal Pharmaceuticals under which the newly-formed company will focus …

News
mr058666-web

Merck appoints Maya Martinez-Davis as global head of oncology

April 14, 2016
Medical Communications Merck, maya martinez-davis, oncology

Merck has announced the appointment of Maya Martinez-Davis as the new global head of oncology at the German-based company. In …

Appointment
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026